These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35518290)

  • 21. Optimized Methods for the Production and Bioconjugation of Site-Specific, Alkyne-Modified Glucagon-like Peptide-1 (GLP-1) Analogs to Azide-Modified Delivery Platforms Using Copper-Catalyzed Alkyne-Azide Cycloaddition.
    Alavi SE; Cabot PJ; Yap GY; Moyle PM
    Bioconjug Chem; 2020 Jul; 31(7):1820-1834. PubMed ID: 32543833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formazanate boron difluoride dyes: discrepancies between TD-DFT and wavefunction descriptions.
    Laurent AD; Otten E; Le Guennic B; Jacquemin D
    J Mol Model; 2016 Nov; 22(11):263. PubMed ID: 27730380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectroscopic and Electrochemical Properties of Electronically Modified Cycloplatinated Formazanate Complexes.
    Kabir E; Patel D; Clark K; Teets TS
    Inorg Chem; 2018 Sep; 57(17):10906-10917. PubMed ID: 30112907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A versatile method for the preparation of conjugates of peptides with DNA/PNA/analog by employing chemo-selective click reaction in water.
    Gogoi K; Mane MV; Kunte SS; Kumar VA
    Nucleic Acids Res; 2007; 35(21):e139. PubMed ID: 17981837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo evaluation of 64Cu-labeled SarAr-bombesin analogs in gastrin-releasing peptide receptor-expressing prostate cancer.
    Lears KA; Ferdani R; Liang K; Zheleznyak A; Andrews R; Sherman CD; Achilefu S; Anderson CJ; Rogers BE
    J Nucl Med; 2011 Mar; 52(3):470-7. PubMed ID: 21321264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.
    Bandari RP; Jiang Z; Reynolds TS; Bernskoetter NE; Szczodroski AF; Bassuner KJ; Kirkpatrick DL; Rold TL; Sieckman GL; Hoffman TJ; Connors JP; Smith CJ
    Nucl Med Biol; 2014 Apr; 41(4):355-63. PubMed ID: 24508213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.
    Ait-Mohand S; Fournier P; Dumulon-Perreault V; Kiefer GE; Jurek P; Ferreira CL; Bénard F; Guérin B
    Bioconjug Chem; 2011 Aug; 22(8):1729-35. PubMed ID: 21761921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trimetallic Iridium-Nickel-Iridium Bis(formazanate) Assemblies.
    Jiang C; Teets TS
    Inorg Chem; 2022 Jun; 61(23):8788-8796. PubMed ID: 35648657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cationic Boron Formazanate Dyes*.
    Maar RR; Katzman BD; Boyle PD; Staroverov VN; Gilroy JB
    Angew Chem Int Ed Engl; 2021 Mar; 60(10):5152-5156. PubMed ID: 33217138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge-Cell Binding Correlation.
    Maspero M; Cheng X; von Kiedrowski V; Dallanoce C; Wängler B; Hübner R; Wängler C
    Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhodamine-marked bombesin: a novel means for prostate cancer fluorescence imaging.
    Sturzu A; Sheikh S; Echner H; Nägele T; Deeg M; Amin B; Schwentner C; Horger M; Ernemann U; Heckl S
    Invest New Drugs; 2014 Feb; 32(1):37-46. PubMed ID: 23728918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Decade's Progress in the Development of Molecular Imaging Agents Targeting the Growth Hormone Secretagogue Receptor.
    Childs MD; Luyt LG
    Mol Imaging; 2020; 19():1536012120952623. PubMed ID: 33104445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region.
    Barrile F; M'Kadmi C; De Francesco PN; Cabral A; García Romero G; Mustafá ER; Cantel S; Damian M; Mary S; Denoyelle S; Banères JL; Marie J; Raingo J; Fehrentz JA; Perelló M
    Mol Cell Endocrinol; 2019 Dec; 498():110573. PubMed ID: 31499133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of copper(I) catalyzed azide-alkyne [3+2] cycloaddition to the synthesis of template-assembled multivalent peptide conjugates.
    Avrutina O; Empting M; Fabritz S; Daneschdar M; Frauendorf H; Diederichsen U; Kolmar H
    Org Biomol Chem; 2009 Oct; 7(20):4177-85. PubMed ID: 19795056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining aminocyanine dyes with polyamide dendrons: a promising strategy for imaging in the near-infrared region.
    Ornelas C; Lodescar R; Durandin A; Canary JW; Pennell R; Liebes LF; Weck M
    Chemistry; 2011 Mar; 17(13):3619-29. PubMed ID: 21337432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.
    Worm DJ; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Koebberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Pept Sci; 2018 Oct; 24(10):e3119. PubMed ID: 30168238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorine and rhenium substituted ghrelin analogues as potential imaging probes for the growth hormone secretagogue receptor.
    Rosita D; Dewit MA; Luyt LG
    J Med Chem; 2009 Apr; 52(8):2196-203. PubMed ID: 19323558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bombesin analogues for gastrin-releasing peptide receptor imaging.
    Nanda PK; Pandey U; Bottenus BN; Rold TL; Sieckman GL; Szczodroski AF; Hoffman TJ; Smith CJ
    Nucl Med Biol; 2012 May; 39(4):461-71. PubMed ID: 22261143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of bombesin conjugates for targeted PET imaging of tumors.
    Zhang H; Abiraj K; Thorek DL; Waser B; Smith-Jones PM; Honer M; Reubi JC; Maecke HR
    PLoS One; 2012; 7(9):e44046. PubMed ID: 23024746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
    Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.